Senseonics Holdings, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021, at 4:30 p.m. Eastern Time
26 Julho 2021 - 5:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical
technology company focused on the development and commercialization
of long-term, implantable continuous glucose monitoring (CGM)
systems for people with diabetes, today announced that it plans to
release its second quarter 2021 financial results after market
close on Monday, August 9, 2021.
Management will hold a conference call to review the company’s
second quarter 2021 performance starting at 4:30 p.m. (Eastern
Time) on the same day. The conference call will be concurrently
webcast. The link to the webcast will be available on Senseonics
Holdings, Inc. website at www.senseonics.com by navigating to
“Investor Relations,” and then “Events & Publications,” and
will be archived there for future reference. To listen to the
conference call, please dial 1-888-317-6003 (US/Canada) or
1-412-317-6061 (International), passcode 4998185, approximately ten
to five minutes prior to start time.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company
focused on the design, development and commercialization of
transformational glucose monitoring products designed to help
people with diabetes confidently live their lives with ease.
Senseonics' CGM Systems, Eversense® and Eversense® XL, include a
small sensor inserted completely under the skin that communicates
with a smart transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210726005708/en/
Senseonics Investor Contact Lynn Lewis or Philip Taylor
Investor Relations 415-937-5406 investors@senseonics.com
Senseonics (AMEX:SENS)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Senseonics (AMEX:SENS)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024